Early Breast Cancer (EBC)
Verzenio is a prescription medicine used in combination with endocrine (hormone) therapy (tamoxifen or an aromatase inhibitor) to treat adults with HR+, HER2–, node-positive, early breast cancer with a high risk of coming back as determined by your doctor.
It is not known if it is safe and effective in children.Learn how Verzenio can help in HR+, HER2– High-Risk Early Breast Cancer
Metastatic Breast Cancer (MBC)
Verzenio is a prescription medicine to treat adults with HR+, HER2– breast cancer that has spread to other parts of the body (metastasized). It is given with an aromatase inhibitor as an initial endocrine-based therapy. If the cancer has gotten worse after hormone therapy, then Verzenio is given with fulvestrant. If the cancer has gotten worse after both hormone therapy and chemotherapy, then Verzenio is given by itself.
It is not known if it is safe and effective in children.Learn how Verzenio can help in HR+, HER2– Metastatic Breast Cancer
Savings & Support
You shouldn't have to worry about financial concerns when you already have so much on your mind. Learn more about our Savings Card and other treatment support.I'm starting on Verzenio